Over the past several decades, its prevalence has risen at an alarming rate worldwide, reaching pandemic proportions and showing no signs of stabilization [1, 2]
Our IV infusion and injection treatments are science-backed and physician-guided, designed to support your energy, immunity, metabolism, and overall vitality
There are two exceptions that allow a provider to compound a GLP-1 drug: (1) if the drug is not commercially available, and (2) if the compounded drug includes a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the commercially available product. The identified change must be documented appropriately on the prescription or order
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and The Obesity Society
It has required a structural adaptation of workflows, verification processes, and patient communication strategies